Copyright Reports & Markets. All rights reserved.

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Corticosteroids
      • 1.4.3 Phosphodiesterase Type 4 Inhibitors
      • 1.4.4 Bronchodilators
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Retail Pharmacies
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size
    • 2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Regions
      • 2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by by Players
      • 3.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
    • 3.3 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product/Solution/Service
    • 3.4 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2014-2019)
    • 4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 5.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in North America
    • 5.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 5.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 6.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Europe
    • 6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 6.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    7 China

    • 7.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 7.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in China
    • 7.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 7.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 8.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Japan
    • 8.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 8.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 9.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 9.4 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    10 India

    • 10.1 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 10.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in India
    • 10.3 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 10.4 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2014-2019)
    • 11.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players in Central & South America
    • 11.3 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
    • 11.4 Central & South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca
      • 12.1.1 AstraZeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019))
      • 12.1.5 AstraZeneca Recent Development
    • 12.2 Boehringer Ingelheim International GmbH
      • 12.2.1 Boehringer Ingelheim International GmbH Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.2.5 Boehringer Ingelheim International GmbH Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Teva Pharmaceutical Industries
      • 12.5.1 Teva Pharmaceutical Industries Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.5.5 Teva Pharmaceutical Industries Recent Development
    • 12.6 Sunovion Pharmaceuticals
      • 12.6.1 Sunovion Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.6.5 Sunovion Pharmaceuticals Recent Development
    • 12.7 CHIESI Farmaceutici
      • 12.7.1 CHIESI Farmaceutici Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.7.5 CHIESI Farmaceutici Recent Development
    • 12.8 Orion Corporation
      • 12.8.1 Orion Corporation Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.8.5 Orion Corporation Recent Development
    • 12.9 ​Mylan
      • 12.9.1 ​Mylan Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
      • 12.9.4 ​Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2014-2019)
      • 12.9.5 ​Mylan Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Chronic Obstructive Pulmonary Disease (COPD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Obstructive Pulmonary Disease (COPD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AstraZeneca
      Boehringer Ingelheim International GmbH
      GlaxoSmithKline
      Novartis AG
      Teva Pharmaceutical Industries
      Sunovion Pharmaceuticals
      CHIESI Farmaceutici
      Orion Corporation
      ​Mylan

      Market segment by Type, the product can be split into
      Corticosteroids
      Phosphodiesterase Type 4 Inhibitors
      Bronchodilators
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Retail Pharmacies
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Chronic Obstructive Pulmonary Disease (COPD) Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Chronic Obstructive Pulmonary Disease (COPD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Chronic Obstructive Pulmonary Disease (COPD) Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now